Highlights
Recent News
Broadcom’s AI Engine Drives Record Valuation Amid Insider Share Sales
Shares in semiconductor giant Broadcom have surged to a new peak, trading at €321.00 and delivering a staggering 104% gain...
Aixtron’s Institutional Backing Faces a Quarterly Reality Check
The stock of semiconductor equipment maker Aixtron has surged nearly 88% since the start of the year, a rally fueled...
Ocugen’s Legal Gambit Aims to Unlock Funding for Gene Therapy Pipeline
A critical legal hearing scheduled for May 6 in Delaware could resolve a major uncertainty hanging over gene therapy developer...
ImmunityBio’s Founder Fights Back as Legal Deadline Looms
ImmunityBio is navigating a stark divide. While its commercial engine, driven by the cancer drug Anktiva, is firing on all...
Popular
Net Worth
Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode
The U.S. Food and Drug Administration has delivered a potentially fatal blow to Replimune Group Inc., issuing...
Red Cat’s Defense Tech Ecosystem Nears Critical Junctions
Red Cat Holdings is accelerating the development of its autonomous systems ecosystem on multiple fronts, with a...
Eutelsat’s Launchpad: Balancing Explosive LEO Growth with Rocket Reliance
Eutelsat shares surged more than 7% this week, capturing investor attention as the global space industry gathered...
Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment
The stock of telehealth provider Hims & Hers has been under significant pressure, trading roughly 40 percent...